Actively Recruiting

Phase 1
Age: 18Years +
All Genders
NCT05587205

Safety and Tolerability of EO2002

Led by Asociación para Evitar la Ceguera en México · Updated on 2025-12-08

32

Participants Needed

1

Research Sites

214 weeks

Total Duration

On this page

Sponsors

A

Asociación para Evitar la Ceguera en México

Lead Sponsor

E

Emmecell

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this clinical study is to assess the safety of intracameral injection of EO2002 in subjects post-cataract surgery.

CONDITIONS

Official Title

Safety and Tolerability of EO2002

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18 years or older
  • Uncomplicated history of cataract requiring standard cataract extraction with intraocular lens implant surgery
  • Decreased endothelial cell count
Not Eligible

You will not qualify if you...

  • Presence of other corneal disease
  • Macular disease limiting ability to show vision improvement
  • Descemet membrane detachment
  • History of uveitis or ocular inflammatory disease
  • History of incisional glaucoma surgery
  • Incisional eye surgery within 3 months prior to study treatment or prior penetrating or endothelial keratoplasty
  • History of ocular neoplasm
  • Fellow eye vision worse than 35 ETDRS letters (Snellen 20/200)
  • Female who is pregnant, nursing, planning pregnancy, or of childbearing potential not using reliable contraception
  • Participation in another investigational drug trial within last 3 months
  • Any medical or psychological condition interfering with study participation or deemed unsuitable by investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Asociacion para Evitar la Ceguera en Mexico

Mexico City, Mexico City, Mexico, 04030

Actively Recruiting

Loading map...

Research Team

Y

Yara Luna

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

SEQUENTIAL

Primary Purpose

TREATMENT

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here